EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma

Ryan T Hughes, Beverly J Levine, Nelson May, Rachel F Shenker, Jae H Yang, Claire M Lanier, Bart A Frizzell, Kathryn M Greven, Joshua D Waltonen

ORL · 2023 · 85 (5) · 284-293

DOI: 10.1159/000531995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ORL, online erschienen am 30.08.2023. Verfasst von Ryan T Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Deglutition, Oropharyngeal Neoplasms, Papillomavirus Infections, Robotic Surgical Procedures. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The aim of this study was to investigate the impact of primary transoral robotic surgery (TORS) versus radiotherapy (RT) on progression-free survival (PFS), overall survival (OS), and 1-year swallowing function for patients with early-stage HPV-associated oropharyngeal squamous cell carcinoma (OPSCC).

Methods

Patients with stage I-II (AJCC 8th Ed.) HPV-associated OPSCC treated with TORS followed by risk-adapted adjuvant therapy or (chemo)radiotherapy between 2014 and 2019 were identified. PFS, OS, and swallowing outcomes including gastrostomy tube (GT) use/dependence, and Functional Oral Intake Scale (FOIS) change over 1 year were compared.

Results

One hundred sixty-seven patients were analyzed: 116 treated with TORS with or without adjuvant RT and 51 treated with RT (50 chemoRT). The RT group had more advanced tumor/nodal stage, higher comorbidity, and higher rates of concurrent chemotherapy. There were no differences in 3-year PFS (88% TORS vs. 75% RT) or OS (90% vs. 81%) between groups, which persisted after adjusting for stage, age, and comorbidity. GT use/dependence rates were higher in the RT group. Mean (SD) FOIS scores in the TORS group were 6.9 (0.4) at baseline and 6.4 (1.0) at 1 year, compared with 6.7 (0.6) and 5.6 (1.7) for the RT group. Only clinical nodal stage was found to be significantly associated with FOIS change from baseline to 1 year.

Conclusion

There were no differences in PFS or OS between patients treated with primary TORS or RT for early-stage HPV-associated OPSCC. Clinical N2 status is associated with FOIS change at 1 year and may be the major factor affecting long-term swallowing function, irrespective of primary treatment modality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeglutitionOropharyngeal NeoplasmsPapillomavirus InfectionsRobotic Surgical ProceduresHumansHead and Neck NeoplasmsHuman Papillomavirus VirusesSquamous Cell Carcinoma of Head and NeckPostoperative Complications

Stichwörter der Autor:innen

DysphagiaHead and neck cancerOropharyngeal cancerRadiotherapySwallowing functionTransoral robotic surgery

Autor:innen und Institutionen

  • Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
  • Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
  • Department of Otolaryngology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
  • Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina, USA.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Hughes, R. T., Levine, B. J., May, N., Shenker, R. F., Yang, J. H., Lanier, C. M., Frizzell, B. A., Greven, K. M., & Waltonen, J. D. (2023). Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. ORL, 85(5), 284-293. https://doi.org/10.1159/000531995

Vancouver

Hughes RT, Levine BJ, May N, Shenker RF, Yang JH, Lanier CM, et al. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. ORL. 2023;85(5):284-293. doi:10.1159/000531995

BibTeX
@article{Hughes2023,
  author = {Hughes, Ryan T and Levine, Beverly J and May, Nelson and Shenker, Rachel F and Yang, Jae H and Lanier, Claire M and Frizzell, Bart A and Greven, Kathryn M and Waltonen, Joshua D},
  title = {Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma},
  journal = {ORL},
  year = {2023},
  volume = {85},
  number = {5},
  pages = {284--293},
  doi = {10.1159/000531995}
}
Kostenlos starten →